Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study-Reference-Cited by-同舟云学术

Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study

Published:2021-10-28 Issue:3 Volume:29 Page:2104-2113
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Kepenekian Vahan,Péron Julien,You Benoit,Bonnefoy Isabelle,Villeneuve Laurent,Alyami Mohammad,Bakrin Naoual,Rousset Pascal,Benzerdjeb Nazim,Glehen Olivier

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-021-10983-2.pdf

Reference42 articles.

1. Moolgavkar SH, Meza R, Turim J. Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973–2005. Cancer Causes Control. 2009;20:935–44. https://doi.org/10.1007/s10552-009-9328-9.

2. Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol. 2007;18:985–90. https://doi.org/10.1093/annonc/mdl345.

3. Yan TD, Welch L, Black D, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol. 2007;18:827–34. https://doi.org/10.1093/annonc/mdl428.

4. Chua TC, Yan TD, Morris DL. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience. J Surg Oncol. 2009;99:109–13. https://doi.org/10.1002/jso.21177.

5. Yan TD, Deraco M, Baratti D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27:6237–42. https://doi.org/10.1200/JCO.2009.23.9640.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Standardizing eligibility and patient selection for Pressurized Intraperitoneal Aerosol Chemotherapy: A Delphi consensus statement;European Journal of Surgical Oncology;2024-06

2. Transformative Insights;Advances in Bioinformatics and Biomedical Engineering;2024-04-26

3. Impact of Body Mass Index on postoperative pain and opioïd administration after pressurized intraperitoneal aerosol chemotherapy (PIPAC);2023-04-19

4. Impact of Body Mass Index on postoperative pain and opioïd administration after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of peritoneal carcinomatosis.;2023-04-13

5. Impact of centralization of care for malignant peritoneal mesothelioma: A historical cohort study from the Dutch mesothelioma expert centers;European Journal of Surgical Oncology;2023-03